Antidiarrheal, anticaries final monographs lead FDA priority list of OTC publications.
This article was originally published in The Tan Sheet
Executive Summary
ANTIDIARRHEAL, ANTICARIES FINAL MONOGRAPHS LEAD PRIORITY LIST of over-the-counter drug regulatory documents in the works at FDA, according to the agency's "unified agenda," published in the May 8 Federal Register. The final monograph on OTC antidiarrheal products is the closest to publication, according to the timetable.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning